To access this element change to forms mode OFF
Grant Award View - GA268497
A lethal and irresistible combination: Simultaneous targeting of the...
GA ID:
GA268497
Agency:
Department of Health and Aged Care
Approval Date:
19-Jun-2022
Publish Date:
4-Oct-2022
Category:
Medical Research
Grant Term:
19-Jun-2022 to 31-May-2024
Value (AUD):
$1,099,656.14
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
A lethal and irresistible combination: Simultaneous targeting of the SARS-CoV-2 proteases Mpro and PLpro
Purpose:
Drug development to fight the global pandemic caused by the SARS-Cov-2 virus has progressed at a lightning pace, thanks to effective vaccines. Anti-viral compounds are the final piece in this puzzle, but only 2 are currently available to patients. Our program will progress 2 new anti-viral molecules targeting distinct Achille’s heels of the virus and will demonstrate their efficacy, not only as single agents but also in combination, offering a treatment that avoids the emergence of resistance.
GO ID:
GO Title:
MRFF – CRR – 2021 COVID-19 Treatment Access and Public Health Activities Grant Opportunity
Internal Reference ID:
2022/MRF2016781
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA